HF2047
Enrollee required to receive any rebates and discounts accrued directly or indirectly to health carriers.
Legislative Session 94 (2025-2026)
Related bill: SF2176
AI Generated Summary
Purpose of the Bill
The purpose of this bill is to regulate how rebates and discounts from pharmaceutical manufacturers are applied to prescription drug pricing, ensuring that these benefits are passed on to the enrollees at the point of sale in Minnesota. This aims to lower out-of-pocket costs for consumers when purchasing prescription drugs.
Main Provisions
Cost-Sharing Reductions: The bill mandates that any rebates or discounts on prescription drugs must be directly credited to the enrollee's cost-sharing obligations (like deductibles or coinsurance) at the point of sale. This means that when someone buys a prescription drug, the price will be reduced by the total amount of rebates received for that drug.
Definition of Terms: It provides definitions for terms such as "defined cost-sharing," "health carrier," "price protection rebate," and "rebate," to clarify how these terms are applied within the legislation.
Confidentiality of Rebate Information: The bill includes strict confidentiality requirements regarding rebate information. This information is considered a trade secret and must not be publicly disclosed in a way that reveals specific details about products or manufacturers.
Significant Changes to Existing Law
Transparency and Savings: The bill requires transparency in how rebates and discounts affect the cost of prescription drugs for consumers, ensuring they are used to reduce the cost for the buyer at the point of sale.
Regulations on Rebate Disclosure: It establishes new confidentiality rules surrounding the disclosure of rebate information, highlighting its sensitive nature and protecting it as a trade secret.
Enforcement and Penalties: The bill enforces compliance by allowing penalties such as civil fines or license suspension for health carriers or pharmacy benefit managers that fail to adhere to these new rules.
Relevant Terms
- Cost-Sharing
- Rebates and Discounts
- Prescription Drugs
- Health Carrier
- Pharmacy Benefit Manager
- Confidentiality
- Price Protection Rebate
- Trade Secret
Actions
| Date | Chamber | Where | Type | Name | Committee Name |
|---|---|---|---|---|---|
| March 10, 2025 | House | Action | Introduction and first reading, referred to | Commerce Finance and Policy | |
| Showing the 5 most recent stages. This bill has 1 stages in total. Log in to view all stages | |||||
Citations
You must be logged in to view citations.
Progress through the legislative process
Sponsors
You must be logged in to view sponsors.